Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients

MLA

Hwi-yeol Yun, et al. “Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients.” Antimicrobial Agents and Chemotherapy, vol. 66, no. 9, Feb. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b843bed76755ed7bf7f2686e159a4f9f&authtype=sso&custid=ns315887.

APA

Hwi-yeol Yun, Min Jung Chang, Heeyoon Jung, Vincent Chang, Qianwen Wang, Natasha Strydom, Young-Ran Yoon, & Radojka M. Savic. (2023). Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients. Antimicrobial Agents and Chemotherapy, 66(9).

Chicago

Hwi-yeol Yun, Min Jung Chang, Heeyoon Jung, Vincent Chang, Qianwen Wang, Natasha Strydom, Young-Ran Yoon, and Radojka M. Savic. 2023. “Prothionamide Dose Optimization Using Population Pharmacokinetics for Multidrug-Resistant Tuberculosis Patients.” Antimicrobial Agents and Chemotherapy 66 (9). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b843bed76755ed7bf7f2686e159a4f9f&authtype=sso&custid=ns315887.